ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma.

Robert Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.